Comparison of Renal Responses Between Continuous Mycophenolate Mofetil and Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Lupus Nephritis

BACKGROUND: Mycophenolate mofetil (MMF) is extensively used for induction and maintenance therapy in patients with lupus nephritis (LN). Enteric-coated mycophenolate sodium (EC-MPS) was developed to reduce the adverse gastrointestinal effects of MMF. However, the therapeutic efficacy of MMF and EC-M...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Yu-Wan, Hung, Wei-Ting, Chen, Yi-Ming, Hsu, Chiann-Yi, Lin, Ching-Heng, Hsieh, Tsu-Yi, Chen, Hsin-Hua, Hsieh, Chia-Wei, Lin, Ching-Tsai, Lai, Kuo-Lung, Tang, Kuo-Tung, Tseng, Chih-Wei, Chen, Yi-Hsing, Huang, Wen-Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Concise Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860215/
https://www.ncbi.nlm.nih.gov/pubmed/34371515
http://dx.doi.org/10.1097/RHU.0000000000001780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860215/
https://www.ncbi.nlm.nih.gov/pubmed/34371515
http://dx.doi.org/10.1097/RHU.0000000000001780

Ejemplares similares